3 nominees · 7 ballot items.
Election of three Class II directors; advisory vote on executive compensation; ratification of HTL International, LLC as independent registered public accounting firm; issuance of common stock upon conversion of Series AA Convertible Preferred Stock and Series AAA Convertible Preferred Stock in accordance with Nasdaq Listing Rules 5635(b) and 5635(d); approval of an amendment to increase the number of authorized shares of common stock to 1,500,000,000; approval of an amendment to effect a reverse stock split of the common stock at a ratio not less than 1-for-2 and not greater than 1-for-100; and approval of an adjournment of the annual meeting, if necessary.
Election of three Class II directors, David Lazar, Mark Iwicki and Todd Bazemore, to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified.
Non-binding advisory vote on the compensation of Kala Bio, Inc.’s named executive officers as disclosed in the proxy statement (say-on-pay).
Ratify HTL International, LLC as Kala Bio, Inc.’s independent registered public accounting firm for the fiscal year ending December 31, 2025.
Approve the issuance of common stock upon conversion of Series AA Convertible Preferred Stock and Series AAA Convertible Preferred Stock in accordance with Nasdaq Listing Rules 5635(b) and 5635(d).
Approve an amendment to the Restated Certificate of Incorporation to increase the number of authorized shares of common stock to 1,500,000,000.
Approve an amendment to the Restated Certificate of Incorporation to effect a reverse stock split of the common stock at a ratio not less than 1-for-2 and not greater than 1-for-100, with the exact ratio and timing to be determined by the board.
Approve the adjournment of the 2025 annual meeting, if necessary, to solicit additional proxies or in the absence of a quorum.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | 2.25% | 417,517 | $72K |
| 2 | CITADEL ADVISORS LLC | 1.52% | 281,650 | $49K |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 1.17% | 217,791 | $38K |
| 4 | Virtu Financial LLC | 0.82% | 152,197 | $26 |
| 5 | ADAR1 Capital Management, LLC | 0.76% | 141,480 | $24K |
| 6 | GSA CAPITAL PARTNERS LLP | 0.45% | 84,470 | $15 |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 0.33% | 60,549 | $10K |
| 8 | UBS Group AG | 0.32% | 59,656 | $10K |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 0.23% | 43,270 | $7K |
| 10 | JANE STREET GROUP, LLC | 0.19% | 36,000 | $6K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.